<DOC>
	<DOC>NCT01829048</DOC>
	<brief_summary>To evaluate the safety and tolerability of multiple doses of PF 02545920 administered orally to psychiatrically stable subjects with schizophrenia receiving background antipsychotic +/- other adjunctive medication.</brief_summary>
	<brief_title>A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Psychiatrically stable subjects with schizophrenia. Evidence of stable schizophrenia symptomatology greater than or equal to 3 months. Subjects must be on a stable medication treatment regimen greater than or equal to 2 months, including concomitant psychotropic medications. History of seizures or of a condition with risk of seizures. Subjects who have had electroconvulsive therapy within the 6 months prior to randomization. Pregnant or nursing females, and females of child bearing potential.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>PF-02545920</keyword>
	<keyword>safety</keyword>
	<keyword>schizophrenia</keyword>
</DOC>